ANI Pharmaceuticals, Inc. (ANIP)

82.11 +1.38 (+1.71%) USD  |  NASDAQ  |  Dec 24, 12:59
82.17 +0.06 (+0.07%) After-Hours: 13:59
More

ANI Pharmaceuticals CAPEX To Revenue (TTM)

CAPEX To Revenue (TTM) Chart

View CAPEX To Revenue (TTM) for ANIP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View CAPEX To Revenue (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

CAPEX To Revenue (TTM) Range, Past 5 Years

View CAPEX To Revenue (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

CAPEX To Revenue (TTM) Benchmarks

View CAPEX To Revenue (TTM) Benchmarks
Start Trial
CorMedix, Inc. Upgrade
Arcutis Biotherapeutics, Inc. Upgrade
Intellia Therapeutics, Inc. Upgrade
Castle Biosciences, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade